0 Comentários
0 Compartilhamentos
532 Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Faça o login para curtir, compartilhar e comentar!
-
Could Neoantigen Cancer Vaccines Be the Next Breakthrough in Personalized Oncology?Regional Overview of Executive Summary Neoantigen Cancer Vaccine Therapy Market by Size and Share CAGR Value The global neoantigen cancer vaccine therapy market size was valued at USD 986 Million in 2025 and is expected to reach USD 6547.71 Million by 2033, at a CAGR of 26.70% during the forecast period The strategies encompassed in the...0 Comentários 0 Compartilhamentos 385 Visualizações 0 Anterior
-
How Are Personalized Cancer Vaccines Revolutionizing Oncology?Executive Summary Personalized Cancer Vaccines Market Market: Growth Trends and Share Breakdown CAGR Value Data Bridge Market Research analyses that the global personalized cancer vaccines market which was USD 2,34,790.00 million in 2022, is expected to reach USD 3,71,404.60 million by 2030, and is expected to undergo a CAGR of 5.9% during the forecast period of 2023 to 2030. The key...0 Comentários 0 Compartilhamentos 531 Visualizações 0 Anterior
-
Newly Released: mRNA Cancer Vaccines Market Growth and Oncology Innovation Trends" Exactitude Consultancy That Adds Flavour To Your Success" Exactitude Consultancy has just rolled out its latest market research report titled "Mrna Cancer Vaccines And Therapeutics Market. Market Size, Share, Growth Outlook & Industry Analysis Report: By Product Type (Therapeutic Vaccines, Preventive Vaccines), By Application (Prostate Cancer, Lung Cancer, Melanoma), By End User...0 Comentários 0 Compartilhamentos 129 Visualizações 0 Anterior
-
Anti-Cancer Drug Market Companies: Growth, Share, Value, Size, and Insights"Executive Summary Anti-Cancer Drug Market: Share, Size & Strategic Insights Data Bridge Market Research analyses that the global anti-cancer drug market which was USD 1,20,000.00 million in 2022, would rocket up to USD 2,97,000.00 million by 2030, and is expected to undergo a CAGR of 12.0% during the forecast period. The Anti-Cancer Drug report provides CAGR values along with its...0 Comentários 0 Compartilhamentos 4KB Visualizações 0 Anterior